ライフサイエンスコーパス: lower extremity

1 distal (tibial nerve) nerve segments of the lower extremity.

2 d from the upper and lower back and from the lower extremity.

3 is during plaster cast immobilization of the lower extremity.

4 ately lead to amputation of a portion of the lower extremity.

5 uals with plaster cast immobilization of the lower extremity.

6 ntion and 12 (22%) underwent amputation of a lower extremity.

7 subcutaneous metastatic disease of the left lower extremity.

8 ion and minimal chronic swelling of the left lower extremity.

9 t); and 6 required amputation of part of the lower extremity.

10 ular intervention for ischemic ulcers of the lower extremities.

11 part of the body, with predominance for the lower extremities.

12 rogressively worsening edema of her face and lower extremities.

13 ally understudied topic, particularly in the lower extremities.

14 , and confluent plaques predominantly on the lower extremities.

15 n lesions that covered places other than the lower extremities.

16 ts that evaluated deficits in both upper and lower extremities.

17 rosis that results in ischemia mostly in the lower extremities.

18 in the major conduit arteries supplying the lower extremities.

19 t manifestations of venous thrombosis at the lower extremities.

20 he extremities, including the weight-bearing lower extremities.

21 involuntary movements of the right upper and lower extremities.

22 of progressive paralysis of the upper and/or lower extremities.

23 computed tomographic (CT) angiography of the lower extremities.

24 isted liposuction, including 23 upper and 18 lower extremities.

25 n in eight cases, of which seven were in the lower extremities.

26 weakness in the facial, scapular, trunk and lower extremities.

27 mal loss of peripheral nerve function in the lower extremities.

28 annularis telangiectodes of Majocchi on the lower extremities 2 months after initiating isotretinoin

29 imaging and was classified as carotid (53%), lower extremity (41%), upper extremity (3%), and aortic

30 orax (11/77, 14.2%), abdomen (16/77, 20.7%), lower extremity (48/77, 62.3%), and upper extremity (5/7

31 SEEs more frequently involved the lower extremity (58%) than visceral-mesenteric (31%) or

32 The most frequently injured site was the lower extremity (70.2%), and 47.9% of all injuries were

33 sment of global spinal balance together with lower extremity alignment should be strongly recommended

34 reported, especially sensory symptoms in the lower extremities among those treated with oxaliplatin.

35 proximately 2-fold higher risk of below-knee lower extremity amputation (0.17 versus 0.09 events per

36 ascularization (4.0%; 95% CI, 2.6%-5.4%) and lower extremity amputation (2.3%; 95% CI, 0.8%-3.8%).

37 in 2002 through 2014 to analyze patterns of lower extremity amputation in the last year of life comp

38 neficiaries with ESRD underwent at least one lower extremity amputation in their last year of life co

39 arly one in ten patients with ESRD undergoes lower extremity amputation in their last year of life.

40 Lower extremity amputation is common among patients with

41 Persons with lower extremity amputation often exhibit abnormal trunk

42 Despite mild reductions in rates of lower extremity amputation over the past decade, few dat

43 It remains unclear whether the below-knee lower extremity amputation risk extends across the class

44 ith ESRD showed that those who had undergone lower extremity amputation were substantially more likel

45 ent peripheral arterial revascularization or lower extremity amputation, 4.6% died, and the median co

46 and related vascular care in the year before lower extremity amputation, across hospital referral reg

47 o rates after coronary revascularization and lower extremity amputation, and the majority of bleeding

48 ascular events and higher risk of below-knee lower extremity amputation.

49 exploratory safety end point was below-knee lower extremity amputation.

50 evascularization or endovascular surgery and lower extremity amputation.

51 peripheral, coronary revascularization, and lower extremity amputation.

52 MACE) rates, although some increase rates of lower-extremity amputation (LEA).

53 atistics System to compare the incidences of lower-extremity amputation, end-stage renal disease, acu

54 Over 60% of lower extremity amputations are performed in patients wi

55 About 85% of lower extremity amputations in diabetes are attributed t

56 Lower extremity amputations were similarly increased in

57 ized by chronic vessel immaturity leading to lower extremity amputations.

58 V-2) and who underwent CT angiography of the lower extremities and 32 patients who tested negative fo

59 /ED conversion coefficients are provided for lower extremities and allow estimation of ED for commonl

60 matic muscle hernias are not uncommon in the lower extremities and are a rare cause of chronic leg pa

61 tients with venous malformations (VM) of the lower extremities and to demonstrate multidisciplinary t

62 yperkeratotic-affected skin on the upper and lower extremities and trunk, and identified a single, pr

63 ence of VTE after cast immobilization of the lower extremity and (2) to develop a clinical prediction

64 s who had plaster cast immobilization of the lower extremity and that blood was drawn 3 mo after the

65 ambulatory status (McNemar test, P < .001), lower extremity and total motor scores (Wilcoxon signed

66 Surface area contracted in the motor (i.e. lower extremity) and pulvinar thalamus, and striatum; an

67 QI registry, including 8,155 carotid, 21,428 lower extremity, and 5,800 aortic aneurysm repair proced

68 pecific clinical outcomes following carotid, lower extremity, and aortic aneurysm repair procedures.

69 ons, such as head and neck, thorax, abdomen, lower extremity, and upper extremity.

70 nd ankle brachial index >/=1.4 who underwent lower extremity angiograms within 1 year were included.

71 undertaking carotid [aOR:1.04 (0.84-1.28)], lower extremity [aOR:1.03 (0.84-1.26)], and aortic [aOR:

72 ents with peripheral arterial disease of the lower extremities are at higher risk of major vascular c

73 DEXA measurements showed lower extremities are more affected than upper extremiti

74 Inflammatory dermatoses of the lower extremity are often misdiagnosed as cellulitis (ak

75 Importance: Inflammatory dermatoses of the lower extremity are often misdiagnosed as cellulitis (ak

76 ns, multivessel coronary artery disease, and lower extremity arterial disease.

77 CEPT1 was found to be elevated in diseased lower-extremity arterial intima of individuals with peri

78 Epidemiology data for lower-extremity arterial thromboembolism (LET) are limit

79 Coronavirus disease 2019 is associated with lower-extremity arterial thrombosis characterized by a g

80 goal of this study was to determine whether lower-extremity arterial thrombosis was associated with

81 s of limb revascularization in patients with lower-extremity arterial trauma is central to decisions

82 future, it is hopeful that we will treat the lower extremity arteries according to segments, taking i

83 Serial changes in lower extremity arteriogenesis and muscle perfusion were

84 Participants underwent MRI of the lower extremities at baseline and 10-month follow-up (Ja

85 experienced immediate reduction in upper- to lower-extremity blood pressure difference with sustained

86 ost of the lesions (87.5%) were localised in lower extremity bones.

87 ial military training (IMT), particularly in lower-extremity bones such as the tibia.

88 ctor 23 (FGF23), hypophosphataemia, rickets, lower extremity bowing, and growth impairment.

89 Lower extremity bypass grafting is most successful with

90 mptomatic peripheral artery disease includes lower extremity bypass surgery (LEB) and peripheral endo

91 epair, abdominal aortic aneurysm repair, and lower extremity bypass surgery.

92 l quality for patients undergoing colectomy, lower extremity bypass, or all surgical procedures.

93 epair, abdominal aortic aneurysm repair, and lower extremity bypass.

94 equired amputation, and 1 patient required a lower-extremity bypass procedure because of gangrenous t

95 f a large urban hospital with a diagnosis of lower extremity cellulitis between June 2010 and Decembe

96 f a large urban hospital with a diagnosis of lower extremity cellulitis between June 2010 and Decembe

97 Misdiagnosis of lower extremity cellulitis is common and may lead to unn

98 Conclusions and Relevance: Misdiagnosis of lower extremity cellulitis is common and may lead to unn

99 ulitis in patients admitted for treatment of lower extremity cellulitis.

100 ere admitted from the ED with a diagnosis of lower extremity cellulitis.

101 ulitis in patients admitted for treatment of lower extremity cellulitis.

102 ere admitted from the ED with a diagnosis of lower extremity cellulitis.

103 n of AAA risk variants with aneurysms in the lower extremity, cerebral, and iliac arterial beds, and

104 decompressed and confirmed entry into all 4 lower extremity compartments.

105 c, the authors noted an increase in positive lower-extremity CT angiography examinations in patients

106 ard deviations were determined for the given lower-extremity CT examinations for all age groups and f

107 All patients were evaluated by lower extremities CTA protocol allowing similar image qu

108 Incidence rates for lower extremity deep vein thrombosis (DVT) range from 88

109 Pediatric lower extremity deep vein thrombosis (LE-DVT) can lead t

110 rvention in the setting of acute and chronic lower extremity deep venous disease.

111 the test appears reliable for screening for lower extremity deep venous thrombosis at or above a con

112 sound examinations, with 12 cases (16.7%) of lower extremity deep venous thrombosis identified.

113 Lower extremity deep venous thrombosis is prevalent in c

114 interquartile range, 3,176-30,770 ng/mL] for lower extremity deep venous thrombosis vs 2,087 ng/mL [i

115 sis (CDT) in the treatment of acute proximal lower-extremity deep vein thrombosis is increasing in th

116 618 patients were hospitalized for proximal lower-extremity deep vein thrombosis, and 3649 patients

117 and hypertension, as well as more extensive lower extremity disease (all p values <0.05).

118 BICD2 cause SMALED2 (spinal muscular atrophy lower extremity dominant 2), and a subset have recently

119 Ventilation-perfusion imaging and lower extremity Doppler ultrasonography were performed (

120 Patients underwent a screening lower-extremity duplex ultrasound approximately 1 month

121 In a clinical study, 38 patients with lower extremity DVT or controls undergoing FDG-PET were

122 Patients with signs or symptoms of lower extremity DVT, such as swelling (71%) or a crampin

123 ities, failure to thrive, liver dysfunction, lower extremity edema and dysmorphic features.

124 shortness of breath at rest, orthopnea, and lower extremity edema.

125 Lower-extremity edema (LEE) is an underreported complica

126 Conclusion Lower-extremity edema developed in more than 50% of stud

127 Lower-extremity edema portends worse survival.

128 lar cruciate-retaining (CR)-TKR in a virtual lower extremity emulated by a musculoskeletal multibody

129 statins and longitudinal limb salvage after lower extremity endovascular revascularization and lower

130 o been a better mechanistic understanding of lower extremity endovascular treatment using tools such

131 issue bridges identified those patients with lower extremity evoked potentials and better clinical re

132 ured during extremity vascular exposures and lower extremity fasciotomy in fresh cadavers before and

133 ence (r = 0.466, 95%CI: 0.432~0.500), except lower extremity fat (r = 0.088, 95%CI: -0.116~0.285).

134 subsequently recommended radiography of the lower extremities ( Fig 3 ).

135 These included stroke, lower extremity fracture, lower extremity joint replacem

136 edure, spinal cord paralysis, venous injury, lower extremity fracture, pelvic fracture, central line,

137 He has had two lower extremity fractures from falls at construction sit

138 us catheter placement, presence of pelvic or lower extremity fractures, and major surgery), and the p

139 re of fracture healing or weight bearing for lower extremity fractures.

140 Forty lower extremities from 20 adult cadavers, embalmed with

141 Functional (including the lower extremity Fugl-Meyer assessment [LE-FM; primary ou

142 y (SPPB) test is an objective measurement of lower extremity function (walk speed, balance, chair sta

143 n of robust KT candidates and improvement in lower extremity function are potential ways to improve s

144 iew yielded 115 clinical trials of upper and lower extremity function in chronic stroke that used a t

145 d evidence to identify measures of upper and lower extremity function used to date as outcomes in tri

146 were activity limitation assessed using the Lower Extremity Functional Scale (score range, 0-80; hig

147 g musculoskeletal pain into lower back pain, lower extremity (hips, knees, and feet/ankles combined)

148 Here, we performed MRIs of the lower extremities in 36 individuals with FSHD, followed

149 remity compartment syndrome of the upper and lower extremities in adults and children, discuss the un

150 te in life, mostly affecting arteries in the lower extremities in elderly individuals.

151 MRI of the lower extremities included the Dixon sequence, multicomp

152 beam CT scanner capable of imaging upper and lower extremities (including weight-bearing examinations

153 of the 55 incident cases (98%) of bilateral lower extremity inflammatory lymphedema occurred during

154 e 55 trainees (0.4%) who developed bilateral lower extremity inflammatory lymphedema that occurred du

155 ctors were ruled out as sources of bilateral lower extremity inflammatory lymphedema.

156 ducted for every confirmed case of bilateral lower extremity inflammatory lymphedema.

157 Patients in Boston sustained more lower extremity injuries because of the ground-level bom

158 Lower extremity ischemia is also associated with pathoph

159 Among patients presenting with critical lower extremity ischemia, it has been previously documen

160 ritical limb ischemia, marked by intractable lower extremity ischemic rest pain and tissue loss, is a

161 ite the therapeutic effect on both upper and lower extremities, its role in motor control and coordin

162 Previous research has investigated lower extremity joint mechanics between young and elderl

163 to characterize associations between altered lower extremity joint moments and altered trunk dynamics

164 tery bypass graft (CABG), lung resection, or lower extremity joint replacement (LEJR) were identified

165 Lower extremity joint replacement at a BPCI-participatin

166 care fee-for-service beneficiaries who had a lower extremity joint replacement at a BPCI-participatin

167 There were 29441 lower extremity joint replacement episodes in the baseli

168 tiative, Medicare payments declined more for lower extremity joint replacement episodes provided in B

169 Among Medicare patients undergoing lower extremity joint replacement from 2013-2017, the BP

170 m 5.8% (95% CI, 5.8%-5.9%) for patients with lower extremity joint replacement to 18.8% (95% CI, 18.8

171 e included stroke, lower extremity fracture, lower extremity joint replacement, debility, neurologic

172 vement (BPCI) program, bundled paymtents for lower-extremity joint replacement (LEJR) are associated

173 g 12,379 patients (41% female) who underwent lower extremity (LE)-PVI from 2004 to 2009 at 16 hospita

174 es, tetraspasticity with predominance in the lower extremities, mild cerebellar atrophy, and hyperekp

175 riatum (i.e. motor caudate) predicted better lower extremity motor score at 2-years.

176 ) grade and change in upper-extremity motor, lower-extremity motor, light touch, and pin prick scores

177 and overlapping representations of upper and lower extremity movement kinematics in subthalamic units

178 A full lower extremity MRI and a detailed knee MRI were taken.

179 ention targeting physical activity increased lower extremity muscle cross-sectional area in patients

180 xercise training improved exercise capacity, lower extremity muscle strength, and health-related qual

181 escent dye injected into fast or slow twitch lower extremity muscle with slice recordings from the fl

182 udy achieved highly reproducible measures of lower extremity muscles across centers and from day to d

183 ischemia-related pathophysiologic changes in lower extremity muscles and peripheral nerves of people

184 tory individuals with DMD; compare upper and lower extremity muscles by using MRI and (1)H MR spectro

185 In standing, coordinated activation of lower extremity muscles can be simplified by common neur

186 y-stimulating behavioral intervention on the lower extremity muscles of patients with DM1 with longit

187 arteries and microvascular landmarks in the lower extremities of 10 healthy volunteers.

188 connectivity of somatosensory gating in the lower extremities of healthy human participants.

189 functional state of lymphatic vessels in the lower extremities of patients with a Fontan circulation

190 tumor, which preferentially develops in the lower extremities of the body where blood vessels are of

191 extremity endovascular revascularization and lower extremity open surgery.

192 ovascular revascularization procedure in the lower extremities or abdomen in Denmark, from 2000 to 20

193 f the 97 patients who had osteoid osteoma in lower extremities or pelvic bones, 73% had muscular atro

194 ance images (MRI) of patients with VM of the lower extremities, over a six-year period, were reviewed

195 ly poorer vibration perception in the distal lower extremities (P = .008, adjusting for age, height,

196 l revascularization strategy for symptomatic lower extremity PAD is not established.

197 l revascularization strategy for symptomatic lower extremity PAD is not established.

198 reased the adjusted hazard ratio of ischemic lower-extremity PAD (1.54 [95% CI, 1.14-2.10]) (p = 0.00

199 During the follow-up period, ischemic lower-extremity PAD developed in 24.4% of hemodialysis p

200 e associated with the occurrence of ischemic lower-extremity PAD in hemodialysis patients.

201 er in hemodialysis patients in whom ischemic lower-extremity PAD occurred (3.03% [IQR, 2.36-4.54], n

202 se patients until the occurrence of ischemic lower-extremity PAD.

203 utcomes were ODI change at 1 year, change in lower extremity pain (measured on a 0-10 scale; higher s

204 with pain-free participants, those reporting lower extremity pain had greater odds of having poor phy

205 with pain-free participants, those reporting lower extremity pain had significantly lower Impact of W

206 a 1-day history of wobbly gait and bilateral lower extremity paresthesia without confusion.

207 a 1-day history of wobbly gait and bilateral lower extremity paresthesia without confusion.

208 ity of monitoring serial regional changes in lower extremity perfusion has not been examined.

209 terectomy, EVAR, open AAA repair, bypass for lower extremity peripheral arterial disease - in Ontario

210 for improving walking ability in people with lower extremity peripheral artery disease (PAD) are uncl

211 Lower extremity peripheral artery disease (PAD) burden d

212 Lower extremity peripheral artery disease (PAD) is frequ

213 ersions, total number of recommendations for lower extremity peripheral artery disease in the current

214 mined 23,934 consecutive patients undergoing lower extremity peripheral vascular interventions betwee

215 nfrarenal aortic diameter is associated with lower-extremity peripheral artery disease (LE-PAD).

216 Patients with lower-extremity peripheral artery disease (PAD) have gre

217 Most arterial studies investigated lower-extremity peripheral artery disease and acute stro

218 chronic kidney disease is a risk factor for lower-extremity peripheral artery disease.

219 heart disease), brain (ischemic stroke), or lower extremities (peripheral vascular disease).

220 Participants' lower-extremity physical ability was assessed every 3 ye

221 significantly improved exercise capacity and lower extremity power.

222 ect of 12 mo of vitamin D supplementation on lower-extremity power and function in older community-dw

223 ng/mL (on average) over 12 mo did not affect lower-extremity power, strength, or lean mass in older c

224 opment (MCD) or spinal muscular atrophy with lower extremity predominance (SMALED), as well as three

225 mouse model for spinal muscular atrophy with lower extremity predominance and a combination of live-c

226 ic dynein cause spinal muscular atrophy with lower extremity predominance, Charcot-Marie-Tooth diseas

227 e features of BICD2 spinal muscular atrophy, lower extremity predominant are consistent with a pathol

228 BICD2 spinal muscular atrophy, lower extremity predominant most commonly presents with

229 Spinal muscular atrophy, lower extremity-predominant, is characterized by lower l

230 history of peripheral artery disease of the lower extremities (previous peripheral bypass surgery or

231 on costs per year attributed to misdiagnosed lower extremity pseudocellulitis.

232 etrospective analysis of patients undergoing lower extremity PVI in the Vascular Quality Initiative (

233 ng anticoagulation or on DAPT at the time of lower extremity PVI, prescription of DAPT following inte

234 associated with DAPT prescription following lower extremity PVI.

235 dered in differential diagnosis of bilateral lower extremity rash in patients with CD after infectiou

236 ith ustekinumab, she developed new bilateral lower extremity rash initially treated with levofloxacin

237 ear on the musculoskeletal kinematics of the lower extremities remain poorly understood.

238 reductions of 111% and 115% in the upper and lower extremities, respectively, at one year post-operat

239 carotid endarterectomy (8%-IVSR vs. 7%-VSF), lower extremity revascularization (19%-IVSR vs. 16%-VSF)

240 I, 1.09-1.31]; P<0.001) but not MALE or MALE/lower extremity revascularization (HR, 1.02 [95% CI, 0.8

241 15]; P=0.062), and an increased risk of MALE/lower extremity revascularization (HR, 1.08 [95% CI, 1.0

242 57%) patients enrolled based on the previous lower extremity revascularization criterion.

243 ular intervention after endovascular or open lower extremity revascularization for propensity-score m

244 Although lower extremity revascularization is effective in preven

245 in patients with symptomatic PAD undergoing lower extremity revascularization randomized to rivaroxa

246 the addition of rivaroxaban to aspirin after lower extremity revascularization regardless of concomit

247 were comparable between sexes, whereas prior lower extremity revascularization was reported less freq

248 d patient characteristics accounted for 12% (lower extremity revascularization) to 57% (esophagectomy

249 d an ankle-brachial index <=0.80 or previous lower extremity revascularization.

250 (HRs) for any MACE, MALE, and MALE including lower extremity revascularization.

251 l ankle-brachial index </=0.80 or a previous lower extremity revascularization.

252 major cardiac and ischemic limb events after lower extremity revascularization.

253 ated with improved 1-year limb salvage after lower extremity revascularization.

254 peripheral artery disease who have undergone lower-extremity revascularization are at high risk for m

255 peripheral artery disease who had undergone lower-extremity revascularization, rivaroxaban at a dose

256 gradient, systolic blood pressure, upper-to-lower-extremity SBP gradient, aortic isthmus ratio, pres

257 nel recommends that the Fugl-Meyer Upper and Lower Extremity scales be used as primary outcomes in in

258 ons with chronic stroke Fugl-Meyer Upper and Lower Extremity scales showing the strongest evidence fo

259 Those are the Fugl-Meyer Upper Extremity and Lower Extremity scales, Wolf Motor Function Test, Action

260 evere bilateral optic disc edema with distal lower-extremity sensory and motor deficits and electrodi

261 ty of the patients admitted (66.6%) suffered lower extremity soft tissue and bony injuries, and 31 ha

262 tomosis for microsurgical reconstructions of lower extremity soft-tissue defects.

263 1-71) with the unifying feature of prominent lower extremity spasticity, owing to a length-dependent

264 tion studies in all patients associated with lower-extremity spasticity (6), cardiac abnormalities or

265 normal neurologic examination with preserved lower extremity strength and sphincter tone.

266 muscle endurance), isometric knee extension (lower extremity strength), unipedal stance time (static

267 What treatments for lower extremity superficial thrombophlebitis are associa

268 f sensory function beginning distally in the lower extremities that is also characterized by pain and

269 atients developed necrotizing fasciitis of a lower extremity that required amputation, and 1 patient

270 evealed no evidence of pulmonary embolism or lower extremity thrombus.

271 T/CT imaging field to include the vertex and lower extremities (total-body acquisition) affects bone

272 involving upper arm training in concert with lower extremity training can enhance locomotor recovery

273 en Bypass vs Angioplasty and Stenting of the Lower Extremity Trial (ROBUST) is the first prospective

274 ts with secondary lymphedema of the upper or lower extremity (UEL/LEL).

275 d to statewide death data, all patients with lower extremity ulcers and a diagnosis of peripheral art

276 her 50s with cryoglobulinemia and bilateral lower extremity ulcers of 1 year's duration developed ac

277 erstersia gyiorum, in a patient with chronic lower-extremity ulcers, and we review the literature on

278 assic SMS (n = 5, involving the low back and lower extremities), variant SMS (n = 2, limited to 1 lim

279 terectomy (28.8%), arthroplasty (18.8%), and lower extremity vascular bypass (36.4%).

280 grafting, colectomy, ventral hernia repair, lower extremity vascular bypass, lung resection, pancrea

281 nee arthroplasty, ventral hernia repair, and lower extremity vascular bypass.

282 nged from 3.8% for hysterectomy to 14.9% for lower extremity vascular bypass.

283 nded randomized study of patients undergoing lower extremity vascular procedures from 2011 to 2014.

284 ndividual burden caused by acute and chronic lower extremity venous disease is considerable.

285 or colorectal surgery underwent preoperative lower extremity venous duplex (LEVD) immediately before

286 From 14056 lower-extremity venous duplex studies, we identified 697

287 Lower extremities vessel enhancement and image noise wer

288 At examination, strength in both lower extremities was slightly reduced, sensation and re

289 patient had a pacemaker; instead, CT of the lower extremity was performed ( Fig 3a , 3b ).

290 patient had a pacemaker; instead, CT of the lower extremity was performed.

291 Lower extremity weakness predominated (46 [73%]).

292 with 1 week of low back pain and progressive lower extremity weakness.

293 A brief 4-item scale encompassing lower-extremity weakness, cognitive impairment, anemia,

294 Lower extremities were the significantly more affected b

295 showed increased muscle fat fraction in the lower extremities, which correlates with disease duratio

296 terized by inadequate venous return from the lower extremities, which may arise from intravenous obst

297 ables proton and phosphorus MRI of the human lower extremities with high spatial and temporal resolut

298 with scattered non-palpable petechiae on the lower extremities with subsequent involvement of abdomen

299 Radiotracer imaging of the lower extremities with techniques such as PET and SPECT

300 Treating posttraumatic lower extremity wounds can be challenging, especially in